Ireland reports on cancer registry:
This article was originally published in Clinica
Ireland's ministry of health and children has published the fifth annual report of the national cancer registry - Cancer in Ireland, 1994-1998: Incidence, Mortality, Treatment & Survival. During the period covered by the report, some 20,000 new cases of cancer and 7,500 cancer deaths occurred every year. Incidence in Ireland was comparable to EU averages, with skin, colorectal, breast (in women) and prostate (in men) as its most common forms. The registry reports no significant variation in the risk of developing or dying from cancer. The ministry last week announced plans to review the 1996 national cancer strategy (see this page).
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.